<DOC>
	<DOCNO>NCT01613898</DOCNO>
	<brief_summary>The aim propose study evaluate risk cardiovascular disease 'atherogenic ' feature serum CTX determine preclinical atherosclerosis . The study include extensive assessment lipoprotein profile carotid artery intima-media thickness ( cIMT ) measurement . Lipid lipoprotein profile include novel test direct measurement apolipoprotein A1 , B , C2 , C3 plasma level , lipoprotein ( ) level , highly sensitive C-reactive protein level PLAC test measure level lipoprotein-associated phospholipase A2-a vascular-specific inflammatory enzyme implicate formation atherosclerosis</brief_summary>
	<brief_title>Evaluation Carotid IMT Atherogenic Risk Factors Patients With Cerebrotendinous Xanthomatosis</brief_title>
	<detailed_description>Protocol 09-2009 EVALUATION OF CAROTID IMT AND ATHEROGENIC RISK FACTORS IN PATIENTS WITH CEREBROTENDINOUS XANTHOMATOSIS ABSTRACT Cerebrotendinous xanthomatosis ( CTX ) rare disease characterize xanthomatous lesion many tissue , mainly brain . Mutation gene sterol 27-hydroxylase-an enzyme bile acid synthesis cause CTX . The impaired synthesis chenodeoxycholic acid cholesterol result elevate plasma bile cholestanol . The natural course CTX progressive neurologic deterioration childhood adulthood lead diffuse damage central peripheral nervous system eventually death . Cardiovascular involvement CTX probably high : different clinical manifestation cardiovascular disease ( CVD ) report 10.4 % patient CTX . The precise mechanism atherosclerosis CTX unknown may relate cholestanol accumulation vascular subendothelial space . Abnormalities lipoprotein profile described literature , cholesterol level within normal limit CTX . Extensive evaluation CVD risk factor CTX patient group conduct apart small number publication . The aim propose study evaluate risk cardiovascular disease 'atherogenic ' feature serum CTX determine preclinical atherosclerosis . The study include extensive assessment lipoprotein profile carotid artery intima-media thickness ( cIMT ) measurement . Lipid lipoprotein profile include novel test direct measurement apolipoprotein A1 , B , C2 , C3 plasma level , lipoprotein ( ) level , highly sensitive C-reactive protein level PLAC test measure level lipoprotein-associated phospholipase A2-a vascular-specific inflammatory enzyme implicate formation atherosclerosis . This would first attempt conduct extensive evaluation CTX patient group . Research Plan : Study Design Methods Subjects The study population constitute 17 CTX diagnose patient recruit CTX outpatient clinic Parkinson 's disease movement disorder Clinic Sagol Neuroscience Center , Chaim Sheba Medical Center . Patients contact phone mail invite participate . Control group consist age gender match healthy individual . All patient legal guardian sign inform consent . Detailed Plan Study All study participant undergo evaluation include one clinic visit : Visit 1 - A detailed medical history , include demographic data , past medical history , smoke history , use medication , family history dyslipidemia atherosclerotic cardiovascular disease . - Physical examination include height weight measurement , blood pressure , BMI , waist hip circumference . - Blood sample 1 . Fasting Lipid profile : Total cholesterol , HDL-cholesterol , direct LDL-cholesterol Triglycerides ( TG ) 2 . Apolipoprotein profile : 1. apolipoprotein A1 2. apolipoprotein B 3. apolipoprotein C2 4. apolipoprotein C3 c. lipoprotein ( ) [ Lp ( ) ] d. C-Reactive Protein -hsCRP e. Lipoprotein-associated Phospholipase A2 ( Lp-PLA2 ) f. Apo E genotyping g. Plasma cholestanol level h. Fasting plasma glucose Insulin - 12 lead electrocardiogram ( ECG ) - cIMT assessment . Methods : - Laboratory study - Blood sample take overnight fast - Total cholesterol , HDL-cholesterol TG plasma determine colorimetric enzymatic procedure ( Olympus , Ireland ) . - Apolipoprotein A1 , B , C2 , C3 Lp ( ) serum concentration determine immuno-turbidimetric procedure . ( Olympus , Ireland ) . - Direct LDL- determine enzymatic color test . ( Olympus , Ireland ) . - HsCRP- determined turbidimetric immunoassay ( Olympus , Ireland ) - Lp-PLA2 ( PLAC® Test ) - The PLAC Test measure Lp-PLA2 ( lipoprotein-associated phospholipase A2 ) , vascular-specific inflammatory enzyme implicate formation rupture-prone plaque . Turbidimetric Immunoassay Quantitative Determination Lp-PLA2 Human Plasma ( diaDexus , Inc. CA .USA ) The Olympus AU 400 autoanalyzer use above-mentioned measurement . - Apo E genotyping- Apo E genotypes genomic DNA blood determine single nucleotide primer extension Elisa assay . ( Pronto Diagnostics , Tel Aviv , Israel ) - Plasma cholestanol level- measure high-performance liquid chromatography ultraviolet detection ( Halperin et al , ref 10 ) - Glucose -will measure glucose oxidase method ( Olympus AU2700 , Hamburg , Germany ) . - Insulin- measured chemiluminiscent immunometric method ( Immulite 2000 , Diagnostic Products Corporation , Los Angeles , CA ) . - ECG-12 lead electrocardiogram do . ( Mac 1100 , GE medical system , Germany ) Carotid artery Intima-media thickness : Patients undergo color-coded duplex examination neck vessel use 10MHz linear array ultrasound ( Hitachi medical corporation , Tokyo , Japan ) . IMT evaluate common carotid artery ( CCAs ) ≈1.5 cm proximal flow divider , accord standardize guideline . In brief , IMT measure thick plaque-free point near far wall specially design computer program . CCA wall thickness define mean maximum wall thickness near far wall bilaterally . Ultrasound image distal 1 cm far wall common carotid artery obtain compare value normative data set ( age sex match ) . Mean CIMT value far wall right leave common carotid artery report</detailed_description>
	<mesh_term>Xanthomatosis</mesh_term>
	<mesh_term>Xanthomatosis , Cerebrotendinous</mesh_term>
	<criteria>The study population constitute 17 CTX diagnose patient Non CTX patient</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Cerebrotendinous xanthomatosis ( CTX ) ,</keyword>
	<keyword>lipoprotein , atherosclerosis ,</keyword>
	<keyword>carotid artery intima-media thickness ( cIMT ) .</keyword>
</DOC>